MBRX Moleculin Biotech Inc
Company Analysis
Latest News
🟢 Moleculin Biotech is trading 10.14% up today with no clear company-specific catalyst
Moleculin Biotech is trading 10.14% up at $0.63, with no clear company-specific catalyst identified on August 20, 2026. - The latest identifiable company...
🟢 Moleculin Biotech is trading 6.1% up today — no clear company-specific catalyst identified
Moleculin Biotech is trading at $0.61, up 6.07%, with the gain appearing more likely tied to short-term trading, recent momentum, or volatility. - No new...
🔴 Moleculin Biotech is trading 5.3% down today without a clear company-specific catalyst
Moleculin Biotech is trading 5.3% down now at $0.58, with no new company-specific announcement clearly explaining the August 19, 2026 decline. - The latest...
🔴 Moleculin Biotech is trading 5.34% down today despite a broader biotech sector rally
Moleculin Biotech is trading at $0.58 (-5.34%) as the stock declines on no clear company-specific news or announcements. • Trading volume reached 373.38K,...
🟢 Moleculin Biotech is trading 5.88% up in pre-market
Moleculin Biotech is trading 5.88% up at $0.65 after rising from a $0.61 close on August 18, 2026; no new company-specific announcement clearly explains the...
🟢 Moleculin Biotech is trading 6.19% up with no clear company-specific catalyst reported
Moleculin Biotech is trading 6.19% up at $0.64, with no clearly reported company-specific announcement on August 18, 2026 explaining the move. - The August 14...
🟢 Moleculin Biotech is trading 6.17% up in pre-market after positive interim MIRACLE trial results
Moleculin Biotech is trading 6.17% up now at $0.65 after its August 14, 2026 earnings release highlighted positive interim MIRACLE trial results and continued...
Moleculin Biotech's second quarter 2026 loss was $1.40 per share with cash runway into early 2027
Moleculin Biotech reported a net loss of $7.6 million and no revenue for the second quarter of 2026, as the company remains focused on its clinical pipeline....
🟢 Moleculin Biotech is trading 11.55% up today after positive preliminary MIRACLE trial efficacy data
Moleculin Biotech is trading $0.64 (+11.55%) after reporting second-quarter results and positive preliminary MIRACLE trial efficacy data. - The first 45...
🟢 Moleculin Biotech is trading 5% up today after Q2 results and MIRACLE trial progress
Moleculin Biotech is trading 5.01% up at $0.60 after second-quarter 2026 results and MIRACLE progress. - Preliminary results from 45 patients showed complete...
🟢 Moleculin Biotech is trading 5.52% up today as broader equities rise
Moleculin Biotech is trading at $0.55 (+5.52%) as broader equities rise, supporting risk appetite. - The Nasdaq Composite is up 0.62%, while the S&P 500 is up...
🔴 Moleculin Biotech is trading 6.15% down in after-hours trading after a sharp regular-session gain
Moleculin Biotech is trading 6.15% down at $0.49 after closing at $0.52 on August 12, 2026, following a sharp regular-session gain and after-hours reversal. -...
🟢 Moleculin Biotech is trading 10.56% up today after July CPI matched expectations
Moleculin Biotech is trading at $0.49 (+10.56%) amid broader market strength after July CPI matched expectations, reducing immediate rate-hike concerns. - No...
🟢 Moleculin Biotech is trading 5.62% up today as Nasdaq Composite gains 0.66%
Moleculin Biotech is trading 5.62% up at $0.47 amid a stronger broader market, with the Nasdaq Composite up 0.66%. - No verified company-specific announcement...
🔴 Moleculin Biotech is trading 5.84% down in pre-market with no verified company-specific negative announcement identified
Moleculin Biotech is trading 5.84% down at $0.42 after no verified company-specific negative announcement was identified for August 12, 2026. - The weakness...
🔴 Moleculin Biotech is trading 6.7% down in after-hours trading with no verified company-specific negative announcement identified
Moleculin Biotech is trading 6.7% down at $0.42 after-hours, with no verified company-specific negative announcement identified. - It closed at $0.45 on...
🟢 Moleculin Biotech is trading 5.2% up today after Q2 earnings and strong interim MIRACLE data
- Moleculin Biotech is trading at $0.45, up +5.16% on August 11, 2026. - The company announced its Q2 2026 earnings today. - Investor enthusiasm continues...
🟢 Moleculin Biotech is trading 6.88% up in after-hours trading on positive interim MIRACLE leukemia data
Moleculin Biotech is trading 6.88% up at $0.46 after the August 10, 2026 regular session closed at $0.43, with the move appearing linked to lingering...
Moleculin's Leukemia Drug Shows Promise in Hard-to-Treat Patients, but Can a Sub-Penny Stock Survive Its Own Dilution?
Shares shifted as Moleculin Biotech climbed 10% to $0.45 on lingering enthusiasm from July 31 interim data showing its experimental cancer drug working in...
🟢 Moleculin Biotech is trading 10% up today after 37% blinded composite complete remission data
Moleculin Biotech is trading 10% up now at $0.45 after positive blinded MIRACLE AML data continued attracting investor attention. - The company has not...